MedPath

大连胜光药业集团股份有限公司

Ownership
-
Established
2002-09-06
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

59

NMPA:59

Drug Approvals

Isopropiram Fumarate Tablets

Product Name
富马酸异丙吡仑片
Approval Number
国药准字H21023188
Approval Date
Jul 23, 2024
NMPA

Indometacin Enteric-coated Tablets

Product Name
吲哚美辛肠溶片
Approval Number
国药准字H21021005
Approval Date
Jul 23, 2024
NMPA

Erythromycin Enteric-coated Tablets

Product Name
红霉素肠溶片
Approval Number
国药准字H21021276
Approval Date
Jul 23, 2024
NMPA

Nefopam Hydrochloride Tablets

Product Name
盐酸奈福泮片
Approval Number
国药准字H21022126
Approval Date
Jul 23, 2024
NMPA

Clotrimazole Tablets

Product Name
克霉唑片
Approval Number
国药准字H21023979
Approval Date
Jul 23, 2024
NMPA

Pyritinol Hydrochloride Tablets

Product Name
盐酸吡硫醇片
Approval Number
国药准字H21023983
Approval Date
Jul 23, 2024
NMPA

Pentoxyverine Citrate Sulfamethoxazole Bromhexine Hydrochloride and Thinethoporim Tablets

Product Name
枸磺新啶片
Approval Number
国药准字H21024406
Approval Date
Jul 23, 2024
NMPA

Tabellae Acidi Acetyls Alicylici Compositae

Product Name
复方乙酰水杨酸片
Approval Number
国药准字H21022122
Approval Date
Jul 12, 2024
NMPA

Piracetam Tablets

Product Name
吡拉西坦片
Approval Number
国药准字H21021280
Approval Date
Jul 12, 2024
NMPA

Lincomycin Hydrochloride Tablets

Product Name
盐酸林可霉素片
Approval Number
国药准字H21023981
Approval Date
Jul 12, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.